ВПЛИВ МОЛЕКУЛЯРНОГО ФЕНОТИПУ ПУХЛИНИ НА ВИЖИВАНІСТЬ ХВОРИХ НА РАК ШЛУНКА ПІСЛЯ РАДИКАЛЬНОГО ХІРУРГІЧНОГО ВТРУЧАННЯ

ВПЛИВ МОЛЕКУЛЯРНОГО ФЕНОТИПУ ПУХЛИНИ НА ВИЖИВАНІСТЬ ХВОРИХ НА РАК ШЛУНКА ПІСЛЯ РАДИКАЛЬНОГО ХІРУРГІЧНОГО ВТРУЧАННЯ

The strategy for the treatment of gastric cancer (GC), in particular the use of the extended surgical interventions in different countries varies. The different proportion of specific molecular GC subtypes in various populations frequently is not taken in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Datum:2023
Hauptverfasser: Dumanskyi, Yu.V., Kirkilevskyi, S.I., Sulaeva, O.M., Polyasnyi, V.O., Mashukov, A.O., Kovalevska, L.A., Yarema, R.R., Ogorchak, M.A.
Format: Artikel
Sprache:English
Veröffentlicht: PH Akademperiodyka 2023
Schlagworte:
рак шлунка
молекулярна класифікація
біологія пухлини
Online Zugang:https://exp-oncology.com.ua/index.php/Exp/article/view/2022-44-4-1
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Experimental Oncology

Institution

Experimental Oncology
Beschreibung
Zusammenfassung:The strategy for the treatment of gastric cancer (GC), in particular the use of the extended surgical interventions in different countries varies. The different proportion of specific molecular GC subtypes in various populations frequently is not taken into account for comparing treatment outcomes. This pilot study analyzes the association of survival of GC patients after the extended combined surgical interventions depending on the molecular subtype of the tumors. An improved survival for patients with diffuse cancer types (p53–, VEGFR+, HER2/neu+, Ki-67+ phenotype) was demonstrated. The authors propose their point of view on the importance of recognizing GC molecular heterogeneity.

Ähnliche Einträge